Skip to content. | Skip to navigation

National Cancer Institute U.S. National Institutes of Health www.cancer.gov

Navigation

Personal tools

You are here: Home / Protocols / Prostate Upgrading Team Project

Prostate Upgrading Team Project

353
Feng, ZidingFred Hutchinson Cancer Research Center

No involved investigator sites defined.

UNKNOWN
Prostate and Urologic Cancers Research Group

Aim 1: We will develop a risk assessment tool using commonly-collected clinical information from a series of contemporary radical prostatectomies to predict the risk of prostate cancer upgrading to high grade cancer at radical prostatectomy. These data will be combined as a part of our Early Detection Research Network (EDRN) GU Working Group into a risk assessment tool; this tool will be named the EDRN Prostatectomy Upgrading Calculator or (EPUC).

Aim 1: We will develop a risk assessment tool using commonly-collected clinical information from a series of contemporary radical prostatectomies to predict the risk of prostate cancer upgrading to high grade cancer at radical prostatectomy. These data will be combined as a part of our Early Detection Research Network (EDRN) GU Working Group into a risk assessment tool; this tool will be named the EDRN Prostatectomy Upgrading Calculator or (EPUC).

There are currently no biomarkers annotated for this protocol.

No datasets are currently associated with this protocol.


Announcement 04/26/2017

A new funding opportunity associated with the Beau Biden Cancer Moonshot Initiative, Integration and Validation of Emerging Technologies to Accelerate Cancer Research, has been released and is due May 10, 2017. Click here for more information.

Announcement 03/14/2017

Thank you to everyone who made the March 2017 EDRN Steering Committee Meeting a success. The next EDRN Steering Committee Meeting will be on September 12-14, 2017, in Seattle, WA.

EDRN Founder Honored

Dr. Sudhir Srivastava was honored with the Distinguished Service Award from the American Pancreatic Association at the group's annual meeting this year, for his outstanding commitment to pancreatology.